Published on in Vol 9, No 7 (2020): July

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/16162, first published .
Alterations of Gut Microbiota and the Brain-Immune-Intestine Axis in Patients With Relapsing-Remitting Multiple Sclerosis After Treatment With Oral Cladribine: Protocol for a Prospective Observational Study

Alterations of Gut Microbiota and the Brain-Immune-Intestine Axis in Patients With Relapsing-Remitting Multiple Sclerosis After Treatment With Oral Cladribine: Protocol for a Prospective Observational Study

Alterations of Gut Microbiota and the Brain-Immune-Intestine Axis in Patients With Relapsing-Remitting Multiple Sclerosis After Treatment With Oral Cladribine: Protocol for a Prospective Observational Study

Jeske van Pamelen   1 , MD ;   Lynn van Olst   2 , MSc ;   Andries E Budding   3 , MD, PhD ;   BIA Study Group   4 ;   Helga E de Vries   2, 5 , PhD ;   Leo H Visser   1 , MD, PhD

1 Department of Neurology, Elisabeth-TweeSteden Ziekenhuis Hospital, Tilburg, Netherlands

2 Department of Molecular Cell Biology and Immunology, MS Center Amsterdam, Amsterdam University Medical Centers, Amsterdam, Netherlands

3 inBiome, Amsterdam, Netherlands

4 see Acknowledgements, Netherlands

5 Department of Medical Biochemistry, Amsterdam Cardiovascular Sciences, University of Amsterdam, Amsterdam, Netherlands

Corresponding Author:

  • Jeske van Pamelen, MD
  • Department of Neurology
  • Elisabeth-TweeSteden Ziekenhuis Hospital
  • Hilvarenbeekseweg 60
  • Tilburg, 5022GC
  • Netherlands
  • Phone: 31 132212552
  • Email: j.vanpamelen@etz.nl